Literature DB >> 15232651

[Endothelin system and inhalation of iloprost in pulmonary hypertension].

M Bauer1, H Wilkens.   

Abstract

The haemodynamics and vascular proliferation (remodelling) in pulmonary hypertension are unfavourably affected by a malfunction of the endothelial cells of the pulmonary vessels. A characteristic result is reduced formation of endothelial dilators and increased formation of vasoconstrictors. The favourable effects of a blockade of the endothelin (ET) system with receptor antagonists suggest that the increased formation and limited clearance of ET-1 reaches pathogenetic significance. The therapeutic effects of inhaled iloprost on right cardiac haemodynamics and clinical course, could in addition to the direct vasodilatory effect, also be considered to have a favourable influence on the ET system as a pathophysiologically effective mediator system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232651     DOI: 10.1007/s00101-004-0726-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  8 in total

Review 1.  [The physiopathology of sepsis. Current concepts].

Authors:  M Bauer
Journal:  Anaesthesist       Date:  1996-04       Impact factor: 1.041

2.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

3.  Renal actions of endothelin: interaction with prostacyclin.

Authors:  S Y Chou; A Dahhan; J G Porush
Journal:  Am J Physiol       Date:  1990-10

Review 4.  Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.

Authors:  G M Rubanyi; M A Polokoff
Journal:  Pharmacol Rev       Date:  1994-09       Impact factor: 25.468

5.  Characterization of a coronary vasoconstrictor produced by cultured endothelial cells.

Authors:  K A Hickey; G Rubanyi; R J Paul; R F Highsmith
Journal:  Am J Physiol       Date:  1985-05

6.  Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin.

Authors:  R J Barst
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

7.  Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension.

Authors:  Michael Bauer; Heinrike Wilkens; Frank Langer; Sven O Schneider; Henning Lausberg; Hans-Joachim Schäfers
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

8.  Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension.

Authors:  H Wilkens; M Bauer; N Forestier; J König; A Eichler; S Schneider; H J Schäfers; G W Sybrecht
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.